Stock listing

KRX:174900 AbClon, Inc. (앱클론) 주가

Follow AbClon, Inc. into a list and get an email when it puts out news.

Share price · KRX:174900

₩23,350 KRW -1,150 (-4.7%)

Close on Nov 20, 2026

Past year -32.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩22,850 – ₩24,100 KRWNov 20, 2026
Volume
93,384 sharesNov 20, 2026
Market cap
₩465.9B KRWAt the close on Nov 20, 2026 · price × 19.95M shares outstanding
52-week range
₩15,800 – ₩95,800 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩4.23B KRWMedian day 170,512 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
AbClon, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:174900 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩23,350-1,150-4.7%₩23,350₩24,100₩22,85093,384
₩24,500+350+1.4%₩24,200₩26,450₩23,750286,317
₩24,150+1,150+5.0%₩22,700₩24,900₩22,000152,611
₩23,000+50+0.2%₩23,100₩24,200₩22,450169,927
₩22,950+1,100+5.0%₩21,950₩25,350₩21,750199,750
₩21,850-750-3.3%₩22,400₩23,450₩21,800118,838
₩22,600+2,500+12.4%₩20,100₩23,350₩20,000333,974
₩20,100+2,860+16.6%₩17,800₩20,600₩17,500204,043
₩17,240+930+5.7%₩16,310₩18,030₩15,800177,965
₩16,310-2,020-11.0%₩16,850₩17,210₩16,230219,692
₩18,330+510+2.9%₩18,120₩19,500₩18,100138,858
₩17,820+570+3.3%₩17,250₩17,860₩16,410151,777
₩17,250-1,080-5.9%₩18,310₩18,350₩17,250110,100
₩18,330-140-0.8%₩18,320₩19,000₩18,15067,613
₩18,470-1,140-5.8%₩19,520₩21,450₩18,300279,757
₩19,610-1,490-7.1%₩21,000₩21,050₩19,120294,395
₩21,10000.0%₩21,250₩22,350₩20,500257,166
₩21,100-250-1.2%₩21,750₩22,950₩20,900123,447
₩21,350-200-0.9%₩21,200₩22,400₩20,85098,910
₩21,550-1,400-6.1%₩22,400₩22,750₩20,800175,873
₩22,950-700-3.0%₩23,400₩24,300₩22,850200,881
₩23,650+1,100+4.9%₩23,000₩24,600₩22,900180,816
₩22,550-50-0.2%₩22,650₩22,900₩21,500131,676
₩22,600-1,200-5.0%₩23,400₩23,800₩22,300147,984
₩23,800+2,650+12.5%₩21,450₩24,400₩21,150220,639
₩21,150-2,250-9.6%₩22,450₩23,000₩20,700260,224
₩23,400-200-0.8%₩23,750₩24,950₩22,750132,831
₩23,600-1,000-4.1%₩24,350₩24,400₩22,500187,476
₩24,600-950-3.7%₩25,450₩26,700₩24,600171,096
₩25,550-1,350-5.0%₩26,500₩26,600₩25,050186,983
₩26,900-1,900-6.6%₩28,700₩28,700₩26,800165,163
₩28,800+900+3.2%₩28,000₩29,500₩27,300246,927
₩27,900+1,000+3.7%₩27,000₩29,700₩26,750330,955
₩26,900+4,550+20.4%₩22,350₩28,100₩21,900536,798
₩22,350+600+2.8%₩21,550₩23,200₩21,150235,736
₩21,750+2,440+12.6%₩19,350₩22,550₩19,110357,272
₩19,310-290-1.5%₩20,050₩20,250₩19,27094,557
₩19,600+380+2.0%₩19,420₩20,150₩19,40059,853
₩19,220-240-1.2%₩19,740₩20,200₩19,210133,396
₩19,460-100-0.5%₩19,570₩19,860₩19,130117,367
₩19,560-590-2.9%₩20,000₩20,150₩19,200118,482
₩20,150-100-0.5%₩20,350₩20,900₩20,05068,726
₩20,250-450-2.2%₩20,600₩20,600₩19,97047,236
₩20,700+450+2.2%₩20,450₩21,800₩20,000119,188
₩20,250-250-1.2%₩20,500₩20,700₩19,50072,450
₩20,500-350-1.7%₩20,350₩20,800₩19,90080,476
₩20,850-100-0.5%₩20,450₩20,950₩19,98069,987
₩20,950+500+2.4%₩20,450₩21,450₩20,000103,599
₩20,450-1,400-6.4%₩21,850₩22,000₩20,450153,063
₩21,850+250+1.2%₩21,750₩22,300₩21,10096,217
₩21,600+1,200+5.9%₩20,750₩21,900₩20,000163,062
₩20,400-1,900-8.5%₩22,550₩22,650₩20,200209,116
₩22,300-1,400-5.9%₩23,250₩23,750₩22,200130,433
₩23,700-900-3.7%₩24,700₩24,700₩23,200114,025
₩24,600-1,450-5.6%₩25,450₩25,450₩23,400217,916
₩26,050-1,600-5.8%₩27,650₩27,650₩25,050222,845
₩27,650-800-2.8%₩28,500₩28,600₩27,000221,561
₩28,450+150+0.5%₩28,800₩30,000₩27,900195,761
₩28,300-1,850-6.1%₩29,500₩30,150₩26,450320,598
₩30,150+2,600+9.4%₩28,200₩30,800₩27,700347,389
₩27,550-2,550-8.5%₩29,700₩29,700₩26,500193,221
₩30,100+350+1.2%₩31,700₩32,200₩28,450261,766

Splits

1 split · KRX:174900 · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
Ticker
KRX:174900
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

Abclon Wins 396 Million Won Order

Apr 7, 2026

Closed ₩53,500 (+5.1%) on Apr 8, 2026

Abclon Wins 778 Million Won Order

Mar 9, 2026

Closed ₩63,100 (-5.1%) on Mar 9, 2026

All AbClon, Inc. news

AbClon, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Apr 7, 2026 · oldest 2026

Valuation

EV/sales 80.9× against a median of 232×: 5th lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩429.5B KRW
P/E
Loss
EV/sales
80.9×
EV/EBITDA
Negative EBITDA
Price/book
8.8×
Gross margin
12.7%
Operating margin
−336.4%
Net margin
−328.3%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
AbClon, Inc. · KRX:174900US$346.2MUS$319.2Mn/a80.9×n/a8.8×−328.3%0.0×n/a
PureTech Health PLC · LSE:PRTCUS$364.6MUS$160.6Mn/a34.5×n/a0.9×n/a0.1×n/a
Puma Biotechnology Inc · NASDAQ:PBYIUS$364.5MUS$255.9M15.3×1.1×5.8×2.5×10.3%0.0×0.88
Lumosa Therapeutics Co Ltd · TPEX:6535US$362.4MUS$343.2Mn/a329×n/a9.7×n/a0.0×n/a
Aspen Neuroscience, Inc. · NASDAQ:ASPEUS$361.2MUS$288.8Mn/an/an/an/an/an/an/a
Alector, Inc. · NASDAQ:ALECUS$347.6MUS$208.9M8.4×1.2×4.9×3.0×23.9%0.0×1.72
Gongwin Biopharm Holdings Co., Ltd. · TPEX:6617US$347.3MUS$296.6Mn/a232×n/a4.9×−389.6%0.0×n/a
Onconic Therapeutics, Inc. · KRX:476060US$344.5MUS$298.0M19.1×4.9×n/a5.4×29.5%0.0×n/a
Lyell Immunopharma, Inc. · NASDAQ:LYELUS$339.3MUS$196.5Mn/a13,099×n/a1.8×n/a0.2×1.51
Avacta Group PLC · LSE:AVCTUS$338.1MUS$337.5Mn/a2,281×n/a68.5×n/a5.3×n/a
Inovio Pharmaceuticals, Inc. · NASDAQ:INOUS$329.7MUS$7.56Bn/a25,303×3.4×n/an/an/a0.70
Median of the othersUS$347.5MUS$292.7M15.3×232×4.9×4.0×17.1%0.0×1.20

Events

QuarterResultsShare move
Quarter to Dec 31, 2020Feb 4, 2021 · Before open−1.2%

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.71B2.34B2.88B3.41B3.02B2.77B14.4B3.92B3.53B3.12B
Cost of revenue3.57B1.26B807.3M1.03B1.40B1.56B1.38B1.65B1.52B1.34B
Gross profit1.14B1.08B2.07B2.38B1.62B1.21B13.0B2.27B2.01B1.78B
Research and development14.4B13.4B10.7B8.69B9.63B5.86B3.88B2.37B1.72B1.99B
Selling, general and administrative1.42B3.02B2.74B2.22B2.05B1.76B5.84B1.82B1.80B1.35B
Operating income-17.6B-15.6B-11.8B-8.75B-10.2B-6.57B4.28B-1.96B-1.54B-1.61B
Depreciation and amortization1.13B1.49B1.59B1.52B1.39B1.13B500.8M353.2M295.5M276.0M
EBITDA-16.5B-14.1B-10.2B-7.23B-8.83B-5.44B4.78B-1.60B-1.25B-1.33B
Interest expense438.7M900.1M1.35B489.6M178.7M189.0M151.8M000
Income before tax-17.9B-16.3B-12.9B-10.3B-10.2B-6.44B4.70B-1.80B-1.43B-1.54B
Income tax-1.10B2.14B-953.5M57.4M57.1M
Net income-17.9B-16.3B-12.9B-9.25B-10.2B-6.44B2.57B-842.7M-1.48B-1.60B
Earnings per share, basic-898.70-935.52-830.91-604.11-670.10-421.84178.83-58.85-109.01-130.90

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents39.0B18.9B12.3B5.30B765.5M1.54B3.44B6.85B3.83B2.14B
Short-term investments6.00B3.00B5.24B18.8B9.50B18.0B25.0B13.7B13.3B9.50B
Receivables280.3M189.0M48.1M187.1M50.8M132.0M1.80B1.10B291.3M609.6M
Inventory186.6M7.74M2.19M9.99M7.80M16.7M32.7M18.0M18.2M2.43M
Current assets46.0B23.2B19.3B25.0B11.9B21.5B31.1B22.2B17.6B12.5B
Property, plant and equipment24.1B25.2B26.9B17.1B17.9B15.2B5.09B3.03B3.24B
Total assets70.7B48.2B45.4B54.1B29.8B40.1B47.0B28.7B20.9B16.0B
Accounts payable6.96M20.1M234.7M137.9M112.2M213.8M152.6M185.8M135.9M141.9M
Current liabilities9.35B18.1B17.6B8.75B10.0B4.55B5.56B9.17B2.80B1.40B
Long-term debt04.56B05.00B5.00B002.00B
Total debt5.09B5.01B2.00B
Total liabilities10.3B18.8B18.2B17.5B10.5B10.8B11.6B10.0B3.47B4.03B
Shareholders' equity60.4B29.4B27.2B36.6B19.4B29.3B35.4B18.7B17.4B12.0B
Shares outstanding19.9M17.4M15.5M15.3M15.3M15.3M14.4M14.3M13.6M12.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-13.8B-14.4B-9.48B-7.49B-8.64B-5.65B-449.9M3.71B-1.11B-204.9M
Capital spending-617.6M-167.5M-49.8M-75.6M-505.4M-3.44B-10.6B-2.36B-63.7M-242.2M
Free cash flow-14.4B-14.6B-9.53B-7.58B-9.17B-9.09B-16.1B1.35B-1.18B-447.1M
Cash from investing2.07B13.6B-9.46B7.99B3.75B-22.1B-2.89B-3.87B257.8M
Cash from financing18.8B2.89B21.5B-116.8M-8.96M19.1B2.29B6.69B6.69B
Share buybacks17.0M3.08B12.1B0100.0M14.1B2.29B6.69B0
Change in cash20.1B6.61B6.96B4.53B-773.6M-1.90B-3.48B3.08B1.69B-18.6M

Open Financials

Cap table

Built by 6ix from AbClon, Inc.’s releases

Common shares
19,952,129
Fully diluted
19,952,129

Fully diluted

LineShares
Common shares19,952,129

Share count over time

CountShares
Nov 22, 202619,952,129

Open Cap table

Shareholders

HolderSharesValueChangeAs of
iShares Genomics Immunology and Healthcare ETF34,319US$470K+7,289Jul 31, 2026
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund839US$15,055NewJun 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about AbClon, Inc.